Your fact-checks will appear here
Charity which conducts research on cancer
Ten‑year survival for people diagnosed with bowel (colon and rectal) cancer in the UK has risen from roughly 22% in the 1970s to just over 54% by 2018 for colon cancer, and Cancer Research UK currentl...
Five‑year survival for bowel cancer in the UK is commonly reported around 60% for cases diagnosed in the 2010–2014 and similar recent periods; Cancer Research UK data show five‑year survival varying b...
Most expert reviews and guidelines say routine empiric antibiotics to “normalize” a raised PSA are unsupported and unnecessary; when antibiotics are used, clinicians typically wait 2–8 weeks before re...
If PSA rises while imaging shows no visible cancer, clinicians usually confirm the trend, measure PSA doubling time, and may choose closer monitoring, targeted imaging/biopsy or systemic therapy depen...
Current UK-wide five‑year survival for bowel (colorectal) cancer is reported at about 60% (five‑year survival reached 60% for diagnoses in 2010–2014) and almost 60% are predicted to survive ten years ...
The UK’s five- and ten‑year survival for bowel (colorectal) cancer has improved but remains lower than in several peer high‑income countries: five‑year survival in the UK during 2010–2014 was about 60...
Recent, large systematic reviews and randomized trials show nicotine e‑cigarettes can increase quit rates compared with traditional nicotine replacement therapy (NRT) and with non‑nicotine e‑cigarette...
Anal cancer often begins with subtle, easily missed signs — most commonly minor rectal bleeding — and early symptoms frequently mimic benign conditions such as hemorrhoids or fissures, which can delay...
The official NHS England release "Cancer survival in England, cancers diagnosed 2016 to 2020, followed up to 2021" publishes stage‑specific 1‑ and 5‑year net survival estimates for bowel (colon/rectum...
Stage I breast cancer is highly survivable: five‑year relative survival for localized (stage I) disease is about 99% according to multiple U.S. cancer organizations and datasets (American Cancer Socie...
Recent long-term trials show PSA screening can reduce prostate cancer deaths by about 13% over 23 years (absolute risk reduction ~0.22%) but also causes substantial overdiagnosis and harms; expert bod...
Available sources document program eliminations, funding cuts and some terminated grants tied to policy shifts and budget changes between 2017–2020 — most prominently charity-driven cuts at Cancer Res...